Concepts (235)
Concepts are derived automatically from a person's publications.
In this concept 'cloud', the sizes of the concepts are based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the same topic. The largest concepts are those that are most unique to this person.
- Acanthamoeba
- Acute Kidney Injury
- Adenosine
- Administration, Intravenous
- Administration, Oral
- Adolescent
- Adult
- Aftercare
- Age Factors
- Aged
- Aged, 80 and over
- Algorithms
- Amebiasis
- Amino Acid Substitution
- Aminoglycosides
- Angiotensinogen
- Animals
- Anti-Bacterial Agents
- Antibiotic Prophylaxis
- Antifungal Agents
- Anti-HIV Agents
- Anti-Infective Agents
- Anti-Infective Agents, Local
- Antiretroviral Therapy, Highly Active
- Antiviral Agents
- Anus Diseases
- Aspergillus
- Bacteremia
- Bacteria
- Bacterial Load
- Baroreflex
- Basal Ganglia Diseases
- Benzimidazoles
- Betacoronavirus
- beta-Glucans
- Biomarkers
- Biopsy
- Blood
- Breast Neoplasms
- Carbamates
- Carcinoma, Hepatocellular
- Cardiovascular Diseases
- Case-Control Studies
- Catheterization, Central Venous
- Catheter-Related Infections
- Catheters, Indwelling
- Cell- and Tissue-Based Therapy
- Central Venous Catheters
- Cerebrospinal Fluid
- Child
- Child, Preschool
- Cohort Studies
- Coinfection
- Colony Count, Microbial
- Combined Modality Therapy
- Communicable Diseases
- Communicable Diseases, Emerging
- Communication
- Coronavirus Infections
- Cross Infection
- Culex
- Culicidae
- Culture Media
- Demyelinating Diseases
- Dentists
- Diagnosis, Differential
- Disease Models, Animal
- Disease Outbreaks
- Disease Susceptibility
- Disease Vectors
- Disease-Free Survival
- Double-Blind Method
- Drug Compounding
- Drug Resistance, Multiple, Bacterial
- Drug Therapy, Combination
- Drug Utilization
- Encephalitis
- Escherichia coli Infections
- Fatal Outcome
- Fatigue
- Female
- Fluorenes
- Fluoroquinolones
- Forecasting
- Galactose
- Gene Targeting
- Gene Transfer Techniques
- Genetic Variation
- Genital Neoplasms, Female
- Genome, Viral
- Genotype
- Gram-Negative Bacteria
- Gram-Negative Bacterial Infections
- Gram-Positive Bacterial Infections
- Gram-Positive Cocci
- Guidelines as Topic
- Head and Neck Neoplasms
- Heart Rate
- Hematologic Neoplasms
- Hepacivirus
- Hepatitis C
- Hepatitis C, Chronic
- Hepatitis, Viral, Human
- Heterocyclic Compounds, 4 or More Rings
- HIV
- HIV Antibodies
- HIV Infections
- HIV Integrase Inhibitors
- HIV Protease Inhibitors
- HIV-1
- Hospitalization
- Humans
- Hypertension
- Imidazoles
- Immunity
- Immunoassay
- Immunocompromised Host
- Immunogenicity, Vaccine
| - Immunotherapy
- Infant
- Infant, Newborn
- Infection Control
- Infectious Disease Transmission, Patient-to-Professional
- Influenza A Virus, H1N1 Subtype
- Influenza Vaccines
- Influenza, Human
- Interferons
- Intraabdominal Infections
- Invasive Fungal Infections
- Invasive Pulmonary Aspergillosis
- Leukemia, Myeloid, Acute
- Liver Neoplasms
- Lung
- Lung Diseases, Parasitic
- Lung Transplantation
- Lymphoma, Large B-Cell, Diffuse
- Lymphoma, Non-Hodgkin
- Lymphopenia
- Male
- Mannans
- Mass Screening
- Medical Oncology
- Methicillin-Resistant Staphylococcus aureus
- Mice
- Mice, Transgenic
- Microbial Sensitivity Tests
- Middle Aged
- Molecular Sequence Data
- Mosquito Control
- Mouthwashes
- Movement Disorders
- Multiple Myeloma
- Multiple Sclerosis
- Neoplasm Grading
- Neoplasm Staging
- Neoplasms
- Neoplasms, Second Primary
- Neutropenia
- New York
- Nitroglycerin
- North America
- Nucleic Acids
- Occupational Exposure
- Opportunistic Infections
- Oxygen
- Pandemics
- Papillomavirus Infections
- Papillomavirus Vaccines
- Patient Discharge
- Personal Protective Equipment
- Phylogeny
- Pilot Projects
- Pneumonia
- Pneumonia, Viral
- Polyethylene Glycols
- Postoperative Complications
- Povidone-Iodine
- Practice Patterns, Dentists'
- Predictive Value of Tests
- Pre-Eclampsia
- Pre-Exposure Prophylaxis
- Pregnancy
- Pressoreceptors
- Prevalence
- Primary Prevention
- Prognosis
- Prospective Studies
- Pyridines
- Pyrrolidines
- Quality Improvement
- Receptors, Antigen
- Recurrence
- Referral and Consultation
- Renin
- Reproducibility of Results
- Research
- Respiratory Protective Devices
- Retrospective Studies
- Reverse Transcriptase Inhibitors
- Ribavirin
- Risk Factors
- RNA, Viral
- Saliva
- Secondary Prevention
- Sensitivity and Specificity
- Sequence Analysis, DNA
- Simeprevir
- Social Media
- Sofosbuvir
- Staphylococcal Infections
- Survival Analysis
- Survivorship
- Sustained Virologic Response
- Tablets
- Tertiary Care Centers
- Tertiary Healthcare
- Texas
- Time Factors
- T-Lymphocytes
- Tomography, X-Ray Computed
- Treatment Outcome
- Triazoles
- United States
- Vaccination
- Vaccines
- Valine
- Vancomycin
- Vancomycin Resistance
- Viremia
- Virulence
- Virus Replication
- West Nile Fever
- West Nile virus
- Young Adult
- Zoonoses
|
GRANWEHR's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(235)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(69)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_